These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8137867)

  • 1. ATP-sensitive K+ channel openers inhibit morphine withdrawal.
    Robles LI; Barrios M; Baeyens JM
    Eur J Pharmacol; 1994 Jan; 251(1):113-5. PubMed ID: 8137867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of morphine and potassium channel openers on experimental models of pain in mice.
    Khanna N; Malhotra RS; Mehta AK; Garg GR; Halder S; Sharma KK
    Fundam Clin Pharmacol; 2011 Aug; 25(4):479-84. PubMed ID: 20880384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.
    Sellers AJ; Boden PR; Ashford ML
    Br J Pharmacol; 1992 Dec; 107(4):1068-74. PubMed ID: 1467829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of diazoxide and cromakalim-induced activation of potassium channels in cultured rat and RINm5F insulin-secreting cells; effects of GTP.
    Harding EA; Jaggar JH; Ayton BJ; Dunne MJ
    Exp Physiol; 1993 Jan; 78(1):25-34. PubMed ID: 8448011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K+ channel openers delay intestinal transit and have antidiarrheal activity.
    Poggioli R; Benelli A; Arletti R; Cavazzuti E; Bertolini A
    Eur J Pharmacol; 1995 Dec; 287(2):207-9. PubMed ID: 8749038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs.
    Ocaña M; Del Pozo E; Barrios M; Baeyens JM
    Br J Pharmacol; 1995 Mar; 114(6):1296-302. PubMed ID: 7620721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cromakalim (BRL 34915) and diazoxide activate ATP-regulated potassium channels in insulin-secreting cells.
    Dunne MJ; Yule DI; Gallacher DV; Petersen OH
    Pflugers Arch; 1989; 414 Suppl 1():S154-5. PubMed ID: 2674892
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of diazoxide and cromakalim with ATP-regulated K+ channels in rodent and clonal insulin-secreting cells.
    Jaggar JH; Harding EA; Ayton BJ; Dunne MJ
    J Mol Endocrinol; 1993 Feb; 10(1):59-70. PubMed ID: 8452640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells.
    Dunne MJ; Aspinall RJ; Petersen OH
    Br J Pharmacol; 1990 Jan; 99(1):169-75. PubMed ID: 2184910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial KATP channel as a receptor for potassium channel openers.
    Garlid KD; Paucek P; Yarov-Yarovoy V; Sun X; Schindler PA
    J Biol Chem; 1996 Apr; 271(15):8796-9. PubMed ID: 8621517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG; Plant TD; Henquin JC
    Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of diazoxide on ATP-K+ currents recorded from an insulin-secreting cell line.
    Kozlowski RZ; Hales CN; Ashford ML
    Br J Pharmacol; 1989 Aug; 97(4):1039-50. PubMed ID: 2676059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti- and proconvulsive actions of levcromakalim, an opener of ATP-sensitive K+ channel, in the model of hippocampus-generating partial seizures in rats.
    Katsumori H; Ito Y; Higashida H; Hashii M; Minabe Y
    Eur J Pharmacol; 1996 Sep; 311(1):37-44. PubMed ID: 8884234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
    Ripoll C; Lederer WJ; Nichols CG
    J Pharmacol Exp Ther; 1990 Nov; 255(2):429-35. PubMed ID: 2243335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cromakalim and pinacidil on 86Rb efflux from guinea pig urinary bladder smooth muscle.
    Trivedi S; Stetz S; Levin R; Li J; Kau S
    Pharmacology; 1994 Sep; 49(3):159-66. PubMed ID: 7972330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.